Christian Brander
CSO and co-founder
AT
AELIX Therapeutics
The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$13.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a therapeutic vaccine utilizing a T-cell immunogen designed to elicit a robust immune response against HIV. This approach aims to provide a potential cure for HIV infection, offering patients a pathway to overcome a chronic viral disease.